Perceptual Learning Approaches for Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how different types of training, including Perceptual Learning Approaches, can improve cognitive tasks like memory and problem-solving. Participants will engage in various training methods to determine which ones most effectively boost mental performance. The trial seeks individuals with normal vision and no known neurological issues. Those with good eyesight and no history of brain-related conditions may be suitable candidates for this study. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research in cognitive enhancement techniques.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that many cognitive training programs, like those in this study, are generally safe for participants. For example, studies on Complex Features (CF) and other methods have demonstrated benefits without serious side effects. These programs often enhance thinking skills and assist with tasks like driving safely, without major adverse effects.
Endogenous Attention Training (EnAT) and Exogenous Attention Training (ExAT) have also yielded positive results. Research indicates that these programs can enhance attention and reduce boredom without causing harm.
Long Training (LT) and Mixed Difficulty (MD) are types of cognitive training studied in older adults. They are considered safe and help maintain mental abilities over time.
Multisensory Facilitation (MF) uses multiple senses to boost cognitive function. Studies suggest it can lessen symptoms like agitation in older adults with dementia, without significant risks.
Noise Training (NT) is another method that has been explored. It has improved attention without notable negative side effects, especially in older adults.
Parafoveal Training (PT) and Short Staircases (SS) are less common but also aim to improve specific mental skills. They have shown cognitive benefits without reported safety concerns.
Standard Perceptual Learning (SPL) and Stimulus Variety (SV) have been part of studies showing modest improvements in thinking skills. They are generally safe for participants, with no reports of significant adverse effects.
Finally, Training with Flankers (TWF) is used to improve conflict resolution skills and has been studied in older adults without major safety issues.
Overall, these cognitive training methods are well-tolerated and focus on improving mental skills without causing harm. Participants in similar studies have not reported serious adverse events, suggesting these methods are safe.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative perceptual learning methods to address cognitive impairment. Unlike traditional treatments that often rely on medication or generic cognitive exercises, these approaches personalize training to target specific brain functions. Techniques like Exogenous and Endogenous Attention Training are designed to enhance attention by focusing on external and internal cues, respectively. Multisensory Facilitation stands out by engaging multiple senses simultaneously, which may lead to more robust cognitive improvements. By exploring these varied methods, the trial aims to uncover which techniques are most effective in enhancing brain function and offer new hope for cognitive rehabilitation.
What evidence suggests that this trial's treatments could be effective for cognitive impairment?
Research has shown that different types of brain training can improve thinking skills. In this trial, participants may receive Standard Perceptual Learning (SPL), which studies find can greatly enhance abilities in tasks like distinguishing fine details, thereby improving the brain's ability to process visual information through practice. Another arm of the trial involves Noise Training (NT), where some research suggests that training focused on listening can boost attention and help people understand speech better in noisy environments. Participants may also undergo Training with Flankers (TWF), where evidence indicates that practicing certain tasks can improve movement and thinking skills, especially when combined with physical exercise. Lastly, Multisensory Facilitation (MF) is another treatment option in this trial, shown to calm agitation and improve thinking skills, particularly in older adults with dementia, by engaging multiple senses.678910
Who Is on the Research Team?
C. Shawn Green
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for individuals between 18 and 30 years old with corrected vision of at least 20/40. They should not have any history of retinal pathology or neurological disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo perceptual learning tasks across 12 separate conditions to assess the effects of training on cognitive and perceptual performance.
Crossover Training
Younger cohort participants undergo a crossover design to train on two tasks sequentially to examine learning and generalization.
Follow-up
Participants are monitored for safety and effectiveness after training, with assessments on transfer to visual search, auditory attention, and reading.
What Are the Treatments Tested in This Trial?
Interventions
- Complex Features (CF)
- Endogenous Attention Training (EnAT)
- Exogenous Attention Training (ExAT)
- Long Training (LT)
- Mixed Difficulty (MD)
- Multisensory Facilitation (MF)
- No Contact Control
- Noise Training (NT)
- Parafoveal Training (PT)
- Short Staircases (SS)
- Standard Perceptual Learning (SPL)
- Stimulus Variety (SV)
- Training with Flankers (TWF)
Complex Features (CF) is already approved in European Union, United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Eye Institute (NEI)
Collaborator